Literature DB >> 2383076

A seasonal pattern in the onset of polymyalgia rheumatica.

M A Cimmino1, R Caporali, C M Montecucco, S Rovida, E Baratelli, M Broggini.   

Abstract

The seasonal distribution in the onset of polymyalgia rheumatica (PMR) was determined in 58 patients with the disease and compared with that in 44 patients affected by rheumatoid arthritis of elderly onset (EORA). Thirty six (62%) cases of PMR developed during May to August; by contrast, only 14 (31%) cases of EORA developed in the same months, this latter disease failing to show any seasonal clustering. The monthly distribution of PMR correlated with outside temperature and hours of sunshine. These data suggest that PMR might be triggered by such factors as actinic damage of superficial vessels or infective agents with a seasonal cycle. Finally, the summer clustering of PMR may be helpful in the differential diagnosis from EORA.

Entities:  

Mesh:

Year:  1990        PMID: 2383076      PMCID: PMC1004141          DOI: 10.1136/ard.49.7.521

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study.

Authors:  B Dasgupta; O Duke; V Kyle; D G Macfarlane; B L Hazleman; G S Panayi
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

2.  Vascular accidents after actinic (solar) exposure. An aspect of the temporal arteritis/polymyalgia rheumatica syndrome.

Authors:  J P O'Brien
Journal:  Int J Dermatol       Date:  1987 Jul-Aug       Impact factor: 2.736

3.  Raised plasma metenkephalin in patients who habitually mutilate themselves.

Authors:  J Coid; B Allolio; L H Rees
Journal:  Lancet       Date:  1983-09-03       Impact factor: 79.321

4.  Abnormalities of peripheral blood T lymphocyte subsets in polymyalgia rheumatica.

Authors:  G Chelazzi; M Broggini
Journal:  Clin Exp Rheumatol       Date:  1984 Oct-Dec       Impact factor: 4.473

5.  Polymyalgia rheumatica and giant cell arteritis: histocompatibility typing and hepatitis-B infection studies.

Authors:  P H Bridgeford; M Lowenstein; T S Bocanegra; F B Vasey; B F Germain; L R Espinoza
Journal:  Arthritis Rheum       Date:  1980-04

6.  Finding causes of seasonal diseases using time series analysis.

Authors:  C Bowie; D Prothero
Journal:  Int J Epidemiol       Date:  1981-03       Impact factor: 7.196

7.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

8.  Decrease of the OKT8 positive T cell subset in polymyalgia rheumatica. Lack of correlation with disease activity.

Authors:  C Benlahrache; P Segond; L Auquier; J P Bouvet
Journal:  Arthritis Rheum       Date:  1983-12

9.  Prognosis and management of polymyalgia rheumatica.

Authors:  J G Jones; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

10.  An evaluation of criteria for polymyalgia rheumatica.

Authors:  H A Bird; W Esselinckx; A S Dixon; A G Mowat; P H Wood
Journal:  Ann Rheum Dis       Date:  1979-10       Impact factor: 19.103

View more
  12 in total

1.  Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study.

Authors:  Rossana Scrivo; Maria Chiara Gerardi; Iolanda Rutigliano; Paola Sessa; Daniele Mipatrini; Gaetana Maria Grazia Stricchiola; Elena Pacella; Alessio Altobelli; Chiara Castellani; Cristiano Alessandri; Fulvia Ceccarelli; Manuela Di Franco; Roberta Priori; Valeria Riccieri; Antonio Sili Scavalli; Francesca Romana Spinelli; Giuseppe La Torre; Fabrizio Conti; Guido Valesini
Journal:  Clin Rheumatol       Date:  2018-05-07       Impact factor: 2.980

Review 2.  Genetic and environmental factors in polymyalgia rheumatica.

Authors:  M A Cimmino
Journal:  Ann Rheum Dis       Date:  1997-10       Impact factor: 19.103

3.  Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis.

Authors:  M Cutolo; C M Montecucco; L Cavagna; R Caporali; S Capellino; P Montagna; L Fazzuoli; B Villaggio; B Seriolo; A Sulli
Journal:  Ann Rheum Dis       Date:  2006-04-27       Impact factor: 19.103

Review 4.  "In sickness and in health": the peculiar occurrence of polymyalgia rheumatica in married cohabiting couples--a case series and review of the literature.

Authors:  Maria Chiara Gerardi; Iolanda Maria Rutigliano; Rossana Scrivo; Roberta Priori; Valeria Riccieri; Guido Valesini
Journal:  Clin Rheumatol       Date:  2014-04-13       Impact factor: 2.980

5.  Long term treatment of polymyalgia rheumatica with deflazacort.

Authors:  M A Cimmino; G Moggiana; C Montecucco; R Caporali; S Accardo
Journal:  Ann Rheum Dis       Date:  1994-05       Impact factor: 19.103

Review 6.  Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.

Authors:  Dario Camellino; Andrea Giusti; Giuseppe Girasole; Gerolamo Bianchi; Christian Dejaco
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

7.  Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.

Authors:  L Smeeth; C Cook; A J Hall
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

8.  Induction of remission is difficult due to frequent relapse during tapering steroids in Korean patients with polymyalgia rheumatica.

Authors:  Hyoun-Ah Kim; Jisoo Lee; You-Jung Ha; Sang-Hyon Kim; Chan-Hee Lee; Hyo-Jin Choi; Han-Joo Baek; Mie Jin Lim; Won Park; Sungiae Choi; Yeon-Sik Hong; Yoo-Hyun Lee; Bo-Ram Koh; Chang-Hee Suh
Journal:  J Korean Med Sci       Date:  2011-12-19       Impact factor: 2.153

Review 9.  Epidemiology and optimal management of polymyalgia rheumatica.

Authors:  P Labbe; P Hardouin
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 4.271

10.  Characteristics of Korean Patients with Polymyalgia Rheumatica: a Single Locomotive Pain Clinic Cohort Study.

Authors:  Jong Geol Do; Jinyoung Park; Duk Hyun Sung
Journal:  J Korean Med Sci       Date:  2018-08-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.